Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction

Clinical Science

Volumn 129, Issue 7, 2015, Pages 547-559

  Zhou, Mi ^a   Bao, Yuqian ^a   Li, Haobo ^b   Pan, Yong ^c,d   Shu, Lingling ^c,d   Xia, Zhengyuan ^b,c,d   Wu, Donghai ^e   Lam, Karen S L ^c,d   Vanhoutte, Paul M ^c,d   Xu, Aimin ^c,d   Jia, Weiping ^a   Hoo, Ruby L C ^c,d  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Adipocyte fatty acid binding protein; Cardiac dysfunction; Diabetes; Endothelial nitric oxide synthase nitric oxide (eNOS NO) pathway; Ischaemic heart disease; Myocardial ischaemia reperfusion

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID BINDING PROTEIN 4; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE; ANION; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FEMALE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; SHAM PROCEDURE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WILD TYPE; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DIABETES MELLITUS; FLUORESCENCE MICROSCOPY; GENETICS; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANIONS; APOPTOSIS; BLOOD PRESSURE; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; FATTY ACID-BINDING PROTEINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; REPERFUSION INJURY; SUPEROXIDES;

EID: 84942859081     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150073     Document Type: Article

References (49)

1. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S. et al. (2013) Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127, 143-152
2. Braunwald, E. and Kloner, R.A. (1985) Myocardial reperfusion: a double-edged sword? J. Clin. Invest. 76, 1713-1719
3. Norhammar, A., Lindback, J., Ryden, L., Wallentin, L. and Stenestrand, U., Register of Information and Knowledge about Swedish Heart Intensive Care (2007) Improved but still high short-and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart 93, 1577-1583
4. Feuvray, D., Idell-Wenger, J.A. and Neely, J.R. (1979) Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ. Res. 44, 322-329
5. Furuhashi, M. and Hotamisligil, G.S. (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7, 489-503
6. Xu, A., Wang, Y., Xu, J.Y., Stejskal, D., Tam, S., Zhang, J., Wat, N.M., Wong, W.K. and Lam, K.S. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 52, 405-413
7. Blaha, V., Musil, F., Smahelova, A., Ticha, A., Hyspler, R., Haluzik, M., Lesna, J. and Sobotka, L. (2012) Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus. Neuro Endocrinol. Lett. 33 (Suppl. 2), 6-12
8. Tso, A.W., Xu, A., Sham, P.C., Wat, N.M., Wang, Y., Fong, C.H., Cheung, B.M., Janus, E.D. and Lam, K.S. (2007) Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30, 2667-2672
9. Veniant, M.M., Hale, C., Helmering, J., Chen, M.M., Stanislaus, S., Busby, J., Vonderfecht, S., Xu, J. and Lloyd, D.J. (2012) FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. PLoS One 7, e40164
10. Bao, Y., Lu, Z., Zhou, M., Li, H., Wang, Y., Gao, M., Wei, M. and Jia, W. (2011) Serum levels of adipocyte fatty acid-binding protein are associated with the severity of coronary artery disease in Chinese women. PLoS One 6, e19115
11. von Eynatten, M., Breitling, L.P., Roos, M., Baumann, M., Rothenbacher, D. and Brenner, H. (2012) Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler. Thromb. Vasc. Biol. 32, 2327-2335
12. Baessler, A., Lamounier-Zepter, V., Fenk, S., Strack, C., Lahmann, C., Loew, T., Schmitz, G., Bluher, M., Bornstein, S.R. and Fischer, M. (2014) Adipocyte fatty acid-binding protein levels are associated with left ventricular diastolic dysfunction in morbidly obese subjects. Nutr. Diabetes 4, e106
13. Lamounier-Zepter, V., Look, C., Alvarez, J., Christ, T., Ravens, U., Schunck, W.H., Ehrhart-Bornstein, M., Bornstein, S.R. and Morano, I. (2009) Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ. Res. 105, 326-334
14. Balci, M.M., Arslan, U., Firat, H., Kocaoglu, I., Vural, M.G., Balci, K.G., Maden, O., Gurbuz, O.A., Ardic, S. and Yeter, E. (2012) Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome. J. Investig. Med. 60, 1020-1026
15. Liu, M., Zhou, M., Bao, Y., Xu, Z., Li, H., Zhang, H., Zhu, W., Zhang, J., Xu, A., Wei, M. et al. (2013) Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure. Clin. Sci. (Lond.) 124, 115-122
16. Djousse, L., Bartz, T.M., Ix, J.H., Kochar, J., Kizer, J.R., Gottdiener, J.S., Tracy, R.P., Mozaffarian, D., Siscovick, D.S., Mukamal, K.J. et al. (2013) Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study. Eur. J. Heart Fail. 15, 394-399
17. Brutsaert, D.L. (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev. 83, 59-115
18. Katz, S.D., Hryniewicz, K., Hriljac, I., Balidemaj, K., Dimayuga, C., Hudaihed, A. and Yasskiy, A. (2005) Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111, 310-314
19. Lee, M.Y., Li, H., Xiao, Y., Zhou, Z., Xu, A. and Vanhoutte, P.M. (2011) Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. Br. J. Pharmacol. 162, 1564-1576
20. Aragones, G., Saavedra, P., Heras, M., Cabre, A., Girona, J. and Masana, L. (2012) Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc. Diabetol. 11, 72
21. Chan, C.K., Zhao, Y., Liao, S.Y., Zhang, Y.L., Lee, M.Y., Xu, A., Tse, H.F. and Vanhoutte, P.M. (2013) A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium. ACS Chem. Neurosci. 4, 122-129
22. Bae, S. and Zhang, L. (2005) Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J. Pharmacol. Exp. Ther. 315, 1125-1135
23. Tao, L., Gao, E., Jiao, X., Yuan, Y., Li, S., Christopher, T.A., Lopez, B.L., Koch, W., Chan, L., Goldstein, B.J. et al. (2007) Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115, 1408-1416
24. Hoo, R.L., Lee, I.P., Zhou, M., Wong, J.Y., Hui, X., Xu, A. and Lam, K.S. (2013) Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. J. Hepatol. 58, 358-364
25. Lambert, J.M., Lopez, E.F. and Lindsey, M.L. (2008) Macrophage roles following myocardial infarction. Int. J. Cardiol. 130, 147-158
26. Yu, Q., Gao, F. and Ma, X.L. (2011) Insulin says NO to cardiovascular disease. Cardiovasc. Res. 89, 516-524
27. Hotamisligil, G.S., Johnson, R.S., Distel, R.J., Ellis, R., Papaioannou, V.E. and Spiegelman, B.M. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274, 1377-1379
28. Marti, C.N., Gheorghiade, M., Kalogeropoulos, A.P., Georgiopoulou, V.V., Quyyumi, A.A. and Butler, J. (2012) Endothelial dysfunction, arterial stiffness, and heart failure. J. Am. Coll. Cardiol. 60, 1455-1469
29. Pieper, G.M. (1998) Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31, 1047-1060
30. Scherrer-Crosbie, M., Ullrich, R., Bloch, K.D., Nakajima, H., Nasseri, B., Aretz, H.T., Lindsey, M.L., Vancon, A.C., Huang, P.L., Lee, R.T. et al. (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104, 1286-1291
31. Brunner, F., Maier, R., Andrew, P., Wolkart, G., Zechner, R. and Mayer, B. (2003) Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc. Res. 57, 55-62
32. Lefer, A.M. and Lefer, D.J. (1996) The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc. Res. 32, 743-751
33. Seddon, M., Shah, A.M. and Casadei, B. (2007) Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc. Res. 75, 315-326
34. Pinsky, D.J., Patton, S., Mesaros, S., Brovkovych, V., Kubaszewski, E., Grunfeld, S. and Malinski, T. (1997) Mechanical transduction of nitric oxide synthesis in the beating heart. Circ. Res. 81, 372-379
35. Godecke, A., Heinicke, T., Kamkin, A., Kiseleva, I., Strasser, R.H., Decking, U.K., Stumpe, T., Isenberg, G. and Schrader, J. (2001) Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J. Physiol. 532, 195-204
36. Finkel, T. (2003) Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254
37. Grieve, D.J. and Shah, A.M. (2003) Oxidative stress in heart failure. More than just damage. Eur. Heart J. 24, 2161-2163
38. Boudina, S., Sena, S., O'Neill, B.T., Tathireddy, P., Young, M.E. and Abel, E.D. (2005) Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112, 2686-2695
39. Beckman, J.S. and Koppenol, W.H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424-C1437
40. Cai, H. and Harrison, D.G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844
41. Tibbles, L.A. and Woodgett, J.R. (1999) The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55, 1230-1254
42. Sun, M., Dawood, F., Wen, W.H., Chen, M., Dixon, I., Kirshenbaum, L.A. and Liu, P.P. (2004) Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110, 3221-3228
43. Kaneko, K., Kanda, T., Yokoyama, T., Nakazato, Y., Iwasaki, T., Kobayashi, I. and Nagai, R. (1997) Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction. Res. Commun. Mol. Pathol. Pharmacol. 97, 3-12
44. Lorenzo, O., Picatoste, B., Ares-Carrasco, S., Ramirez, E., Egido, J. and Tunon, J. (2011) Potential role of nuclear factor kappaB in diabetic cardiomyopathy. Mediators Inflamm. 2011, 652097
45. Makowski, L., Boord, J.B., Maeda, K., Babaev, V.R., Uysal, K.T., Morgan, M.A., Parker, R.A., Suttles, J., Fazio, S., Hotamisligil, G.S. et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7, 699-705
46. Hui, X., Li, H., Zhou, Z., Lam, K.S., Xiao, Y., Wu, D., Ding, K., Wang, Y., Vanhoutte, P.M. and Xu, A. (2010) Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J. Biol. Chem. 285, 10273-10280
47. Porter, K.E. and Turner, N.A. (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123, 255-278
48. Aoyagi, T. and Matsui, T. (2011) The cardiomyocyte as a source of cytokines in cardiac injury. J. Cell Sci. Ther. 2012, 003
49. Fukuchi, M., Hussain, S.N. and Giaid, A. (1998) Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy. Circulation 98, 132-139